Clinical Trials
2 trialsNCT06434610 2026-05-05
A Study of B013 in Combination With Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer.
Shanghai Jiaolian Drug Research and Development Co., Ltd
Phase 2 Recruiting
NCT06687070 2025-02-26
APG-2449 Monotherapy or in Combination With PLD in Patients With Platinum-resistant Recurrent OC or Advanced ST
Ascentage Pharma Group Inc.
Phase 1 Recruiting